16 articles for T Yoshida
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Interaction Analysis of FABP4 Inhibitors by X-ray Crystallography and Fragment Molecular Orbital Analysis.

Ajinomoto
Correlation analyses on binding affinity of substituted benzenesulfonamides with carbonic anhydrase using ab initio MO calculations on their complex structures (II).

The University of Tokushima Graduate School
Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

Mitsubishi Tanabe Pharma
Synthesis of phenserine analogues and evaluation of their cholinesterase inhibitory activities.

Meiji Pharmaceutical University
Fused bicyclic heteroarylpiperazine-substituted L-prolylthiazolidines as highly potent DPP-4 inhibitors lacking the electrophilic nitrile group.

Mitsubishi Tanabe Pharma
Discovery of potent and orally active tricyclic-based FBPase inhibitors.

Daiichi Sankyo
Lead optimization of [(S)-gamma-(arylamino)prolyl]thiazolidine focused on gamma-substituent: Indoline compounds as potent DPP-IV inhibitors.

Mitsubishi Pharma
Synthesis and phospholipase A2 inhibitory activity of thielocin B3 derivatives.

Shionogi
Discovery of a novel EP2/EP4 dual agonist with high subtype-selectivity.

Minase Research Institute
3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. Part 3: Synthesis, metabolic stability, and biological evaluation of optically active analogs.

Minase Research Institute
A prodrug approach towards the development of tricyclic-based FBPase inhibitors.

Daiichi Sankyo
[(S)-gamma-(4-Aryl-1-piperazinyl)-l-prolyl]thiazolidines as a novel series of highly potent and long-lasting DPP-IV inhibitors.

Mitsubishi Pharma
5-

University of Toyama
Synthesis and structure-activity relationship study of antimicrotubule agents phenylahistin derivatives with a didehydropiperazine-2,5-dione structure.

Tokyo University of Pharmacy and Life Sciences
Hexylitaconic acid: a new inhibitor of p53-HDM2 interaction isolated from a marine-derived fungus, Arthrinium sp.

Kanazawa University
2-pyridyloxy-4-nitrile orexin receptor antagonists

TBA